CCP-RIZATRIPTAN ODT

cellchem pharmaceuticals inc.🇨🇦 Health Canada

Approval Id: ea367875b56f75f4
Drug Approval Canada Name: CCP-RIZATRIPTAN ODT
Product Name: CCP-RIZATRIPTAN ODT
Status: Cancelled Post Market
Status Date: 2023-08-03
Original Market Date: 2019-01-04
Din: 02458772
Drug Class: Human
Dosage Form: Tablet (Orally Disintegrating)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:32.28
Atc Original: N02CC04 RIZATRIPTAN
Atc Name: n 02 cc 04
Aig Number: 0137841002
Company Name: cellchem pharmaceuticals inc.
Company Address: UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7

RIZATRIPTAN (RIZATRIPTAN BENZOATE)

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ea367875b56f75f4

Type

Standard